Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 95 Records) |
Query Trace: Oligodendroglioma[original query] |
---|
Radiological differences between subtypes of WHO 2016 grade II-III gliomas: a systematic review and meta-analysis. Neuro-oncology advances 0 2 (1): vdaa044. van Lent Djuno I, van Baarsen Kirsten M, Snijders Tom J, Robe Pierre A J |
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1. Neuro-oncology advances 0 2 (1): vdaa042. Alghamri Mahmoud S, Thalla Rohit, Avvari Ruthvik P, Dabaja Ali, Taher Ayman, Zhao Lili, Ulintz Peter J, Castro Maria G, Lowenstein Pedro |
Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges. Neuropathology and applied neurobiology 2021 9 48 (2): e12769. Métais Alice, Appay Romain, Pagès Mélanie, Gallardo Catherine, Silva Karen, Siegfried Aurore, Perbet Romain, Maurage Claude-Alain, Scavarda Didier, Fina Frédéric, Uro-Coste Emmanuelle, Riffaud Laurent, Colin Carole, Figarella-Branger Dominique, |
Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC cancer 2021 Sep 21 (1): 1025. Makino Yasuhide, Arakawa Yoshiki, Yoshioka Ema, Shofuda Tomoko, Minamiguchi Sachiko, Kawauchi Takeshi, Tanji Masahiro, Kanematsu Daisuke, Nonaka Masahiro, Okita Yoshiko, Kodama Yoshinori, Mano Masayuki, Hirose Takanori, Mineharu Yohei, Miyamoto Susumu, Kanemura Yonehi |
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation. Journal of neuropathology and experimental neurology 2021 8 80 (9): 821-829. Ida Cristiane M, Johnson Derek R, Nair Asha A, Davila Jaime, Kollmeyer Thomas M, Minn Kay, Fadra Numrah M, Balcom Jessica R, Fung Kar-Ming A, Kim Dong Kun, Kaufmann Timothy J, Kipp Benjamin R, Halling Kevin C, Jenkins Robert B, Giannini Cateri |
Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma. Brain pathology (Zurich, Switzerland) 2021 8 32 (1): e13011. Wang Yujiao, Wang Leiming, Blümcke Ingmar, Zhang Weiwei, Fu Yongjuan, Shan Yongzhi, Piao Yueshan, Zhao Guogua |
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma. Brain tumor pathology 2021 8 38 (4): 271-282. Kim Seong-Ik, Lee Kwanghoon, Bae Jeongmo, Lee Sungyoung, Yun Hongseok, Park Chul-Kee, Choi Seung Hong, Maquiling Christopher Alec, Park Sung-Hye, Won Jae-Kyu |
Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients. Frontiers in cell and developmental biology 2021 7 9 679684. Wu Zijun, Wang Dan, Zeng Fanxin, Zhang Yanrong, Zhu Guannan, Ma Yiqi, Song Bin, Lui Su, Wu M |
Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas. Molecular and clinical oncology 2021 6 15 (2): 150. Ruiz María Fernanda, Gennaro María Verónica, Bastone Laura C, Godoy Alicia R, Torruella Mónica, Perez Germán |
Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Neuro-oncology advances 2021 4 1 (1): vdz001. Wijnenga Maarten M J, van der Voort Sebastian R, French Pim J, Klein Stefan, Dubbink Hendrikus J, Dinjens Winand N M, Atmodimedjo Peggy N, de Groot Marius, Kros Johan M, Schouten Joost W, Dirven Clemens M F, Vincent Arnaud J P E, Smits Marion, van den Bent Martin |
Seizure in Indonesian Glioma Patients: Associated Risk Factors and Impact on Survival. Asian Pacific journal of cancer prevention : APJCP 2021 3 22 (3): 691-697. Hartanto Rahmat Andi, Dwianingsih Ery Kus, Panggabean Andre Stefanus, Wicaksono Adiguno Suryo, Dananjoyo Kusumo, Asmedi Ahmad, Malueka Rusdy Ghaza |
Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion. World neurosurgery 2021 2 149 e1174-e1179. Zhu Jin, Hu Li-Bo, Zhao Ya-Peng, Zhang Yu- |
Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects. Neuro-oncology 2021 2 23 (8): 1383-1392. Tschernichovsky Roi, Katz Lior H, Derazne Estela, Berliner Matan Ben-Zion, Simchoni Maya, Levine Hagai, Keinan-Boker Lital, Benouaich-Amiel Alexandra, Kanner Andrew A, Laviv Yosef, Honig Asaf, Dudnik Elizabeth, Siegal Tali, Mandel Jacob, Twig Gilad, Yust-Katz Shlom |
SNP-based detection of allelic imbalance: A novel approach for identifying KIAA1549-BRAF fusion in pilocytic astrocytoma using DNA sequencing. Experimental and molecular pathology 2021 2 120 104621. Bobach Ida Schwartz, Stougaard Magn |
TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy. Cancers 2021 11 13 (21): . Noor Humaira, Briggs Nancy E, McDonald Kerrie L, Holst Jeff, Vittorio Oraz |
The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study. Journal of neurology 2021 10 269 (5): 2627-2633. Mazzucchi Edoardo, Vollono Catello, Pauletto Giada, Lettieri Christian, Budai Riccardo, Gigli Gian Luigi, Sabatino Giovanni, La Rocca Giuseppe, Skrap Miran, Ius Tama |
PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas. Scientific reports 2022 8 12 (1): 14083. Rautajoki Kirsi J, Jaatinen Serafiina, Tiihonen Aliisa M, Annala Matti, Vuorinen Elisa M, Kivinen Anni, Rauhala Minna J, Maass Kendra K, Pajtler Kristian W, Yli-Harja Olli, Helén Pauli, Haapasalo Joonas, Haapasalo Hannu, Zhang Wei, Nykter Mat |
Variant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis. Neurologia 2022 8 . Gomez-Pinedo U, Matías-Guiu J A, Torre-Fuentes L, Montero-Escribano P, Hernández-Lorenzo L, Pytel V, Maietta P, Alvarez S, Sanclemente-Alamán I, Moreno-Jimenez L, Ojeda-Hernandez D, Villar-Gómez N, Benito-Martin M S, Selma-Calvo B, Vidorreta-Ballesteros L, Madrid R, Matías-Guiu |
The First Case Report of a Patient With Oligodendroglioma Harboring CHEK2 Germline Mutation. Frontiers in genetics 2022 3 13 718689. Li Xueen, Xue Hao, Luo Ningning, Han Tiantian, Li Mengmeng, Jia De |
The IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma. Epilepsy & behavior reports 2022 2 18 100526. Vo Anh Huan, Ambady Prakash, Spencer Dav |
Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center. Journal of neuro-oncology 2022 12 . Qiu Xianxin, Gao Jing, Hu Jiyi, Yang Jing, Hu Weixu, Huang Qingting, Zhang Haojiong, Lu Jiade J, Kong L |
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-oncology 2022 12 . Alpen Karen, Vajdic Claire M, MacInnis Robert J, Milne Roger L, Koh Eng-Siew, Hovey Elizabeth, Harrup Rosemary, Bruinsma Fiona, Nguyen Tuong L, Li Shuai, Joseph David, Benke Geza, Dugué Pierre-Antoine, Southey Melissa C, Giles Graham G, Rosenthal Mark, Drummond Katharine J, Nowak Anna K, Hopper John L, Kapuscinski Miroslaw, Makalic En |
CIMP-positive glioma is associated with better prognosis: A systematic analysis. Medicine 2022 Sep 101 (39): e30635. Xu Yingying, Xiao Huashi, Hu Wenqing, Shen He-Chun, Liu Wanjun, Tan Siyuan, Ren Chuanli, Zhang Xiaomin, Yang Xishuai, Yu Guo, Yang Ting, Yu Duonan, Zong Lia |
MUC17 mutations and methylation are associated with poor prognosis in adult-type diffuse glioma patients. Journal of the neurological sciences 2023 8 452 120762. Gabriel Cardoso Machado, Valéria Pereira Ferr |
Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement. Neuroradiology 2023 6 . Koji Yamashita, Osamu Togao, Kazufumi Kikuchi, Daisuke Kuga, Yuhei Sangatsuda, Yutaka Fujioka, Izumi Kinoshita, Makoto Obara, Koji Yoshimoto, Kousei Ishiga |
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis. Anticancer research 2023 5 43 (6): 2659-2670. Pietro Familiari, Pierfrancesco Lapolla, Veronica Picotti, Mauro Palmieri, Alessandro Pesce, Giulia Carosi, Michela Relucenti, Stefania Nottola, Francesca Gianno, Simone Minasi, Manila Antonelli, Alessandro Frati, Antonio Santoro, Giancarlo D'Andrea, Placido Bruzzaniti, Biagia LA Pi |
Treating oligodendroglioma - An analysis of a homogeneous 1p/19q-codeleted and isocitrate dehydrogenase-mutant patient cohort. Clinical and translational radiation oncology 2023 5 41 100626. Luisa Allwohn, Josy Wolfgang, Julia Onken, David Wasilewski, Siyer Roohani, Daniel Zips, Felix Ehret, David Ka |
Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis. Scientific reports 2023 5 13 (1): 6761. Kwanghoon Lee, Seong-Ik Kim, Eric Eunshik Kim, Yu-Mi Shim, Jae-Kyung Won, Chul-Kee Park, Seung Hong Choi, Hongseok Yun, Hyunju Lee, Sung-Hye Pa |
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: